Newberry E P, Latifi T, Battaile J T, Towler D A
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Biochemistry. 1997 Aug 26;36(34):10451-62. doi: 10.1021/bi971008x.
Osteocalcin (OC) is a calcium binding protein expressed in mature osteoblasts undergoing mineralization. The OC gene has been identified as a target for transcriptional suppression by Msx2, a homeodomain transcription factor that controls ossification in calvarial bone of the developing skull. We have initiated systematic structure-function analyses of Msx2, using OC promoter suppression (luciferase reporter) in MC3T3-E1 calvarial osteoblasts as an assay. Msx2 variants were epitope ("FLAG")-tagged for monitoring Msx2 protein expression by Western blot analysis. Functional analyses of N- and C-terminally truncated molecules identify Msx2 residues 97-208 as the core suppressor domain. Internal deletion analyses indicate that suppressor function is dependent upon structural features encoded by residues 132-148--upstream of the homeodomain and overlapping the homeodomain N-terminal extension--but not upon residues in the three homeodomain helices. Mutations that enhance DNA binding activity do not proportionally enhance Msx2 suppressor function; moreover, a Msx2 point mutant Msx2(T147A) that completely lacks DNA binding activity is indistinguishable from wild-type Msx2 in its ability to suppress the OC promoter, demonstrating that direct interaction with DNA is not required for Msx2 suppressor function. This suggests that Msx2 suppresses transcription via protein-protein interactions with components of the basal transcriptional machinery, either alone or in concert with co-regulators. Using interaction "Far Western" blotting assays, we systematically tested for protein-protein interactions between Msx2 and components of the basal transcriptional machinery known to mediate transcriptional activation (TBP, TFIIB, and TFIIF). Msx2 binds both components of TFIIF (RAP74, RAP30), but not TFIIB or TBP. Msx2(55-208) encompasses core suppressor domain residues and binds TFIIF; in this context, deletion of the seventeen amino acid residues 132-148 that are required for core suppressor function abrogates interactions with TFIIF components. Co-expression of RAP74 in MC3T3-E1 cells partially reverses (>50%) suppression of OC promoter activity by Msx2, while co-expression of TFIIB or RAP30 has no effect. Thus the core suppressor domain of Msx2 participates in functionally important interactions with RAP74 that regulate OC promoter activity in calvarial osteoblasts.
骨钙素(OC)是一种在经历矿化的成熟成骨细胞中表达的钙结合蛋白。OC基因已被确定为Msx2转录抑制的靶点,Msx2是一种同源结构域转录因子,可控制发育中颅骨颅盖骨的骨化。我们已开始对Msx2进行系统的结构-功能分析,以MC3T3-E1颅盖成骨细胞中的OC启动子抑制(荧光素酶报告基因)作为检测方法。Msx2变体带有表位(“FLAG”)标签,用于通过蛋白质印迹分析监测Msx2蛋白表达。对N端和C端截短分子的功能分析确定Msx2的97-208位残基为核心抑制结构域。内部缺失分析表明,抑制功能取决于132-148位残基编码的结构特征——位于同源结构域上游且与同源结构域N端延伸重叠——而不取决于三个同源结构域螺旋中的残基。增强DNA结合活性的突变不会成比例地增强Msx2抑制功能;此外,一个完全缺乏DNA结合活性的Msx2点突变体Msx2(T147A)在抑制OC启动子的能力上与野生型Msx2没有区别,这表明Msx2抑制功能不需要与DNA直接相互作用。这表明Msx2通过与基础转录机制的成分进行蛋白质-蛋白质相互作用来抑制转录,这种相互作用可以单独发生,也可以与共调节因子协同发生。使用相互作用“Far Western”印迹分析方法,我们系统地测试了Msx2与已知介导转录激活的基础转录机制成分(TBP、TFIIB和TFIIF)之间的蛋白质-蛋白质相互作用。Msx2与TFIIF的两个成分(RAP74、RAP30)结合,但不与TFIIB或TBP结合。Msx2(55-208)包含核心抑制结构域残基并与TFIIF结合;在这种情况下,缺失核心抑制功能所需的132-148位的十七个氨基酸残基会消除与TFIIF成分的相互作用。在MC3T3-E1细胞中共表达RAP74可部分逆转(>50%)Msx2对OC启动子活性的抑制,而共表达TFIIB或RAP30则没有效果。因此,Msx2的核心抑制结构域参与了与RAP74的功能重要相互作用,从而调节颅盖成骨细胞中的OC启动子活性。